E-Abstract

JACC

Lots of interesting abstracts and cases were submitted for TCTAP 2023. Below are the accepted ones after a thorough review by our official reviewers. Don’t miss the opportunity to expand your knowledge and interact with authors as well as virtual participants by sharing your opinion in the comment section!

Category Filter

CORONARY

Acute Coronary Syndromes (STEMI, NSTE-ACS)
Adjunctive Procedures (Thrombectomy, Atherectomy, Special Balloons)
Bifurcation/Left Main Diseases and Intervention
Cardiac Surgery/Hybrid Revascularization
Chronic Total Occlusion
Complex and Higher Risk Procedures for Indicated Patients (CHIP)
Complications (Coronary)
Drug-Eluting Balloons
Hemodynamic Support and Cardiogenic Shock
Pharmacology/Pharmacotherapy
Stents (Bare-metal, Drug-eluting)

ENDOVASCULAR

Carotid & Neurovascular Intervention
Hypertension Therapies and Renal Denervation
Peripheral Vascular Disease and Intervention

IMAGING AND PHYSIOLOGIC LESION ASSESSMENT

Imaging: Intravascular
Imaging: Non-Invasive
Physiologic Lesion Assessment

STRUCTURAL HEART DISEASE

Congenital Heart Disease (ASD, PDA, PFO, VSD)
Hypertrophic Obstructive Cardiomyopathy
Pulmonary Intervention: CTEPH, PHTN
Valvular Intervention: Aortic
Others (Structural Heart Disease)

OTHERS

Basic Science, Animal Models and Preclinical Studies
Cell Therapy and Angiogenesis
Diabetes
Genomics/Proteomics
Innovative Devices and Futuristic Therapies
Quality, Guidelines and Appropriateness Criteria
Renal Insufficiency and Contrast Nephropathy
Vascular Access (Transradial)
Women’s Health Issues
Others (Unclassified)
Total: 105
<Sanofi
<Cordis Korea Ltd.
<Korea Otsuka Pharmaceutical